Stockreport

RedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022) [Yahoo! Finance]

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations
PDF EPS: US$4.00 (up from US$46.29 loss in FY 2022). All figures shown in the chart above are for the trailing 12 month (TTM) period RedHill Biopharma shares are down 6 [Read more]